Stony Brook Medicine Anti-Inflammatory Trial

NCT06699966 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Celecoxib
DRUG: Minocycline

Sponsor

Stony Brook University